These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27517135)

  • 21. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gut microbiota on kidney transplantation.
    Winichakoon P; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Transplant Rev (Orlando); 2022 Jan; 36(1):100668. PubMed ID: 34688985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke.
    Singh V; Roth S; Llovera G; Sadler R; Garzetti D; Stecher B; Dichgans M; Liesz A
    J Neurosci; 2016 Jul; 36(28):7428-40. PubMed ID: 27413153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus: The microbiome angle.
    Yacoub R; Jacob A; Wlaschin J; McGregor M; Quigg RJ; Alexander JJ
    Immunobiology; 2018; 223(6-7):460-465. PubMed ID: 29478734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self.
    Litvak Y; Bäumler AJ
    Immunity; 2019 Aug; 51(2):214-224. PubMed ID: 31433969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue.
    Logan AC; Jacka FN; Prescott SL
    Curr Allergy Asthma Rep; 2016 Feb; 16(2):13. PubMed ID: 26768621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.
    Wu H; Singer J; Kwan TK; Loh YW; Wang C; Tan J; Li YJ; Lai SWC; Macia L; Alexander SI; Chadban SJ
    J Am Soc Nephrol; 2020 Jul; 31(7):1445-1461. PubMed ID: 32482686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
    Ganesan K; Chung SK; Vanamala J; Xu B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet.
    Kong C; Gao R; Yan X; Huang L; Qin H
    Nutrition; 2019 Apr; 60():175-184. PubMed ID: 30611080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.